The Series C funding round included participation from Saudi Arabia’s Public Investment Fund and an undisclosed American health insurance giant, and increases Babylon’s valuation to more than $2 billion. The investment will be used to advance the company’s diagnostic offerings and expand operations to the U.S. and Asia, Ali Parsa, PhD, founder and CEO, said in a statement.
Babylon’s software uses artificial intelligence to aid in the diagnosis and treatment of a wide variety of physical and mental health conditions. Its GP at Hand app, for example, provides NHS patients in the U.K. with a 24/7 telehealth chatbot and directs them toward appropriate primary care physicians if needed.
More articles on health IT:
IBM releases new blockchain network
11 vulnerabilities found in VxWorks operating system, affecting 2B medical devices
Louisiana physician network alerts 116,000 patients of ransomware attack
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
